companydata.dkcompanydata.dk

Scandion Oncology A/S: Financial statements 2019

CVR: 38613391

Source: annual report 2019, Danish Business Authority

01/01/2019 – 31/12/2019

Scandion Oncology A/S (CVR 38613391) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -11,160,744 and a net result of DKK -12,183,591 compared with DKK -8,182,558 the year before. Equity in the 2019 report amounted to DKK 18,338,281. The solvency ratio was 92.1%. The company had 3 employees in the financial year.

Revenue
DKK 0
Gross Profit
DKK -11,160,744
Profit/Loss
DKK -12,183,591
Equity
DKK 18,338,281
Total Assets
DKK 19,902,610
Employees
3

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
20190-11.2M-12.2M18.3M3
20180-7.4M-8.2M12.6M2

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2019

Peter Høngård Andersen joins Scandion Oncology A/S as chairmanOct 1, 2019

As of October 1, 2019, Peter Høngård Andersen is registered as chairman of Scandion Oncology A/S.

Jørgen Vilhelm Løvenørn Bardenfleth joins Scandion Oncology A/S as vice chairmanOct 1, 2019

As of October 1, 2019, Jørgen Vilhelm Løvenørn Bardenfleth is registered as vice chairman of Scandion Oncology A/S.

Peter Høngård Andersen steps down as vice chairman of Scandion Oncology A/SSep 30, 2019

As of September 30, 2019, Peter Høngård Andersen has stepped down as vice chairman of Scandion Oncology A/S.

Jørgen Vilhelm Løvenørn Bardenfleth steps down as chairman of Scandion Oncology A/SSep 30, 2019

As of September 30, 2019, Jørgen Vilhelm Løvenørn Bardenfleth has stepped down as chairman of Scandion Oncology A/S.

Thomas Feldthus joins the board of Scandion Oncology A/SMay 29, 2019

As of May 29, 2019, Thomas Feldthus has joined the board of directors of Scandion Oncology A/S.

Peter Høngård Andersen joins Scandion Oncology A/S as vice chairmanMay 29, 2019

As of May 29, 2019, Peter Høngård Andersen is registered as vice chairman of Scandion Oncology A/S.

Thomas Feldthus steps down as vice chairman of Scandion Oncology A/SMay 28, 2019

As of May 28, 2019, Thomas Feldthus has stepped down as vice chairman of Scandion Oncology A/S.

Scandion Oncology A/S: The 2018 annual report is outMay 20, 2019

Scandion Oncology A/S has published its annual report for 2018. Revenue came to DKK 0, and the net result was DKK -8,182,558.

About Scandion Oncology A/S

Scandion Oncology A/S was a Danish company of the type Aktieselskab based in København Ø, founded in 2017. The company has been dissolved on 6 October 2026. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -6,100,000 and a net result of DKK -8,286,000. Equity in the 2025 report amounted to DKK 0.

Source: annual report 2025, Danish Business Authority

Other financial years